Psychopharmacology for Pediatric Aggression

Joseph C. Blader; Jeffrey H. Newcorn

doi:10.1007/978-3-031-57472-6_13

Psychopharmacology for Pediatric Aggression

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Aggressive, dyscontrolled behavior is a highly impairing complication of numerous psychiatric disorders that affect children and adolescents. In clinical practice, aggressive and other destructive behaviors have long been targets for pharmacotherapy. However, the evidence base to support the multitude of agents and their combinations in widespread use remains limited. This chapter reviews clinical considerations for the pharmacotherapeutic management of aggressive behavior in the context of the “underlying” psychopathology that generates these disturbances. Specific pharmacotherapy treatment approaches to key patient populations are presented, along with their evidence base and practical guidance for their use.

Original language	English (US)
Title of host publication	Pediatric Psychopharmacology Evidence
Subtitle of host publication	A Clinician’s Guide
Publisher	Springer Nature
Pages	275-304
Number of pages	30
ISBN (Electronic)	9783031574726
ISBN (Print)	9783031574719
DOIs	https://doi.org/10.1007/978-3-031-57472-6_13
State	Published - Jan 1 2024

Keywords

Aggression
Attention-deficit hyperactivity disorder
Autism spectrum disorder
Children and adolescents
Evidence
Mood disorders
Pharmacotherapy

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-031-57472-6_13

Cite this

@inbook{d7609add3a034d1e95505e3ad4c0d541,

title = "Psychopharmacology for Pediatric Aggression",

abstract = "Aggressive, dyscontrolled behavior is a highly impairing complication of numerous psychiatric disorders that affect children and adolescents. In clinical practice, aggressive and other destructive behaviors have long been targets for pharmacotherapy. However, the evidence base to support the multitude of agents and their combinations in widespread use remains limited. This chapter reviews clinical considerations for the pharmacotherapeutic management of aggressive behavior in the context of the “underlying” psychopathology that generates these disturbances. Specific pharmacotherapy treatment approaches to key patient populations are presented, along with their evidence base and practical guidance for their use.",

keywords = "Aggression, Attention-deficit hyperactivity disorder, Autism spectrum disorder, Children and adolescents, Evidence, Mood disorders, Pharmacotherapy",

author = "Blader, \{Joseph C.\} and Newcorn, \{Jeffrey H.\}",

note = "Publisher Copyright: {\textcopyright} The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2024.",

year = "2024",

month = jan,

day = "1",

doi = "10.1007/978-3-031-57472-6\_13",

language = "English (US)",

isbn = "9783031574719",

pages = "275--304",

booktitle = "Pediatric Psychopharmacology Evidence",

publisher = "Springer Nature",

address = "United States",

}

TY - CHAP

T1 - Psychopharmacology for Pediatric Aggression

AU - Blader, Joseph C.

AU - Newcorn, Jeffrey H.

N1 - Publisher Copyright: © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2024.

PY - 2024/1/1

Y1 - 2024/1/1

N2 - Aggressive, dyscontrolled behavior is a highly impairing complication of numerous psychiatric disorders that affect children and adolescents. In clinical practice, aggressive and other destructive behaviors have long been targets for pharmacotherapy. However, the evidence base to support the multitude of agents and their combinations in widespread use remains limited. This chapter reviews clinical considerations for the pharmacotherapeutic management of aggressive behavior in the context of the “underlying” psychopathology that generates these disturbances. Specific pharmacotherapy treatment approaches to key patient populations are presented, along with their evidence base and practical guidance for their use.

AB - Aggressive, dyscontrolled behavior is a highly impairing complication of numerous psychiatric disorders that affect children and adolescents. In clinical practice, aggressive and other destructive behaviors have long been targets for pharmacotherapy. However, the evidence base to support the multitude of agents and their combinations in widespread use remains limited. This chapter reviews clinical considerations for the pharmacotherapeutic management of aggressive behavior in the context of the “underlying” psychopathology that generates these disturbances. Specific pharmacotherapy treatment approaches to key patient populations are presented, along with their evidence base and practical guidance for their use.

KW - Aggression

KW - Attention-deficit hyperactivity disorder

KW - Autism spectrum disorder

KW - Children and adolescents

KW - Evidence

KW - Mood disorders

KW - Pharmacotherapy

UR - https://www.scopus.com/pages/publications/105003793335

UR - https://www.scopus.com/inward/citedby.url?scp=105003793335&partnerID=8YFLogxK

U2 - 10.1007/978-3-031-57472-6_13

DO - 10.1007/978-3-031-57472-6_13

M3 - Chapter

AN - SCOPUS:105003793335

SN - 9783031574719

SP - 275

EP - 304

BT - Pediatric Psychopharmacology Evidence

PB - Springer Nature

ER -

Psychopharmacology for Pediatric Aggression

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this